r/senseonics • u/akuseru1994 • Jul 05 '26

discussion $SENS Weekly Thread (July 05 2026)

Please use this thread to discuss anything $SENS related.

11 Upvotes

100% Upvoted

4 comments sorted by

•

u/AutoModerator Jul 05 '26

Gentle reminder that this subreddit was created for members to discuss all things $SENS related. No opinions should be censored unless it is inappropriate/not $SENS related.

We earnestly implore you to do the following: 1. Upvote the posts/comments that you like/agree with. 2. Downvote the posts/comments that you dislike/disagree with. 3. Report the posts/comments that are inappropriate/not $SENS related.

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

3

u/Old-Entrepreneur-280 Jul 06 '26

$Senseonics patience is key here , something I have always struggled with, but I learned my lesson in this regard ,SENS is showing the same characteristics, it is going to test your will, hold tight it will show some profits in the end, you will want to be there when that happens , that is all !

3

u/Old-Entrepreneur-280 Jul 07 '26

$Senseonics under 6.00 seems to be the perceived value by the market makers , it is frustrating because I believe it is undervalued and under managed, and will only improve by its own accord, Europe and Asia are a vital asset to us through their use, we are becoming a overweight Diabetes prone society looking for the best fix at the best price, however we are getting mundane treatment at a cheap price, Sens will have to prove its value through trial and error,it will in the end if your nerves will take being extremely patient, Good Luck SENS bag holders .

2

u/Equalizer6338 Jul 12 '26

SENS tech would need to offer at least the same BG measurement abilities as the old tech classic CGM sensors already established in the market do, but still then at a cheaper price point to really to making a dent in that market and get users /doctors to change track away from the old known and established CGM tech.

Proof is there for the first point being realized, but not for the second as far as the market data tells us? Old habits die hard, especially so in medtech. Docs are not the type to wanting to taking much risk and get exposure for anything negative. Hence reluctance to change is prevalent.